Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC with High vs Low Dose 5-FU in Unresectable HCC
NCT04667351Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
fluorouracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04667351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04667351.